Total Wrist Replacement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Total Wrist Replacement (TWR), Total Wrist Fusion (TWF)), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 262.18 Million
CAGR (2026-2031)	4.81%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America
Market Size (2031)	USD 347.55 Million

Market Overview

The Global Total Wrist Replacement Market is projected to grow from USD 262.18 Million in 2025 to USD 347.55 Million by 2031 at a 4.81% CAGR. Total wrist replacement involves the surgical substitution of a damaged wrist joint with a prosthetic implant to alleviate pain and maintain functional motion, serving as an alternative to wrist fusion. The primary drivers propelling market growth include the rising prevalence of rheumatoid arthritis and osteoarthritis within an aging global population, coupled with a heightened patient preference for preserving joint mobility. These fundamental factors sustain demand as patients increasingly seek treatments that allow them to maintain active lifestyles despite degenerative joint conditions.

However, market expansion is impeded by the significant challenge of implant longevity and high revision rates, which necessitate strict patient selection and limit widespread adoption. This clinical caution is reflected in utilization data, where procedure volumes remain comparatively low. According to the Australian Orthopaedic Association National Joint Replacement Registry, in its 2025 report, the registry recorded a cumulative total of 730 primary total wrist procedures up to December 2024. This figure highlights the specialized nature of the intervention and the continued hesitation surrounding its implementation compared to more established joint replacements.

Key Market Drivers

Technological advancements in implant design and biomaterials have emerged as a critical driver for the Global Total Wrist Replacement Market, directly addressing historical challenges related to prosthesis longevity and stability. Innovators are increasingly utilizing advanced kinematic designs and durable biomaterials to replicate natural wrist motion while minimizing the risk of loosening, which has historically impeded adoption. The market response to these sophisticated solutions is evident in the rapid uptake of next-generation devices. According to Medartis, March 2025, in the 'Annual Report 2024', sales of the TOUCH prosthesis nearly doubled compared to the previous year, underscoring the clinical community's growing confidence in modern motion-preserving implants over traditional fusion options.

Simultaneously, the rising prevalence of rheumatoid arthritis and osteoarthritis creates a substantial and expanding patient pool that prioritizes functional mobility. As the global population ages, the burden of degenerative joint disease intensifies, compelling patients to seek surgical interventions that restore daily activity levels rather than limit them. This demand is quantified by the significant impact of the disease on quality of life; according to the American College of Rheumatology, December 2025, in the 'New National Data Highlights Urgent Need to Address Arthritis Burden', almost half of adults with arthritis reported activity limitations, fueling the necessity for effective surgical solutions. This robust clinical demand contributes to the financial health of the sector, where, according to Stryker, in 2025, the trauma and extremities segment achieved a sales growth of 15% in the second quarter.

Download Free Sample Report

Key Market Challenges

The primary obstacle currently impeding the expansion of the Global Total Wrist Replacement Market is the persistent issue of limited implant longevity and the associated high rates of revision surgery. This challenge directly hampers market growth by necessitating rigorous patient selection criteria, which effectively narrows the addressable patient population to only those with lower functional demands or specific inflammatory conditions. Surgeons often remain reluctant to recommend total wrist arthroplasty for younger or more active patients due to the risk of early mechanical failure, opting instead for wrist fusion procedures that offer greater durability despite the permanent loss of motion.

This clinical hesitation is substantiated by recent surveillance data highlighting performance gaps compared to more established joint replacements. According to the Australian Orthopaedic Association National Joint Replacement Registry, in its 2025 Supplementary Report on Elbow and Wrist Arthroplasty, the cumulative percent revision for primary total wrist replacement reached 18.3% at ten years. Such elevated revision rates discourage widespread adoption and reinforce the procedure's status as a niche intervention rather than a standard of care, thereby restricting broader market penetration and commercial volume growth.

Key Market Trends

The migration of procedures to Ambulatory Surgical Centers (ASCs) is reshaping the market as stakeholders prioritize cost-effectiveness. Surgeons are increasingly performing total wrist replacements in outpatient settings, utilizing improved anesthetic protocols that maintain safety while eliminating expensive inpatient admissions. This trend is accelerating as ASCs optimize their infrastructure to handle complex extremity cases with greater efficiency than traditional hospitals. The scale of this shift is highlighted by utilization data; according to Becker's ASC Review, October 2025, in the article 'The new age of orthopedics in ASCs: 5 trends to know', orthopedic case volume in ambulatory settings rose by 5.5% year-over-year, confirming the sector's expansion.

Simultaneously, the adoption of 3D-printed patient-specific implants is transforming surgical approaches by addressing anatomical variability. Additive manufacturing enables the fabrication of personalized prostheses derived from preoperative imaging, ensuring optimal implant fit and preserving bone stock compared to generic alternatives. This customization is critical for enhancing kinematic function and reducing intraoperative complexity in patients with severe deformities. The commercial traction of these technologies is significant; according to Materialise, February 2025, in the 'Fourth Quarter and Full Year 2024 Results', revenue from the Medical segment grew by 14.8% for the fiscal year, underscoring the escalating demand for personalized surgical solutions.

Segmental Insights

The Hospitals and Clinics segment stands as the fastest-growing category in the Global Total Wrist Replacement Market. This growth is primarily driven by the specialized infrastructure within these facilities, which is critical for the successful execution of complex arthroplasty procedures. A rising prevalence of osteoarthritis and rheumatoid arthritis necessitates the comprehensive care and continuous monitoring that hospitals typically provide. Furthermore, reimbursement structures frequently favor inpatient surgeries, encouraging patients to select these institutions for treatment. Consequently, the ability to manage intricate surgical requirements positions hospitals and clinics as the leading driver of market expansion.

Regional Insights

North America maintains a leading position in the global total wrist replacement market, driven primarily by the high prevalence of osteoarthritis and rheumatoid arthritis within the region. This dominance is supported by a well-established healthcare infrastructure that enables widespread access to orthopedic specialists. Additionally, the local presence of key medical device manufacturers facilitates the rapid distribution of implants. Favorable reimbursement policies and strict quality standards maintained by the U.S. Food and Drug Administration (FDA) further build provider confidence in these procedures. Consequently, these combined factors ensure sustained market expansion across the region.

Recent Developments

• In August 2025, Acumed received FDA clearance for the Acu-Loc NEXT Wrist Fixation System, marking a significant update to its widely used wrist plating portfolio. While primarily a fixation system, this launch is integral to the broader wrist reconstruction market as it addresses complex fracture patterns and osteotomies that are often treated alongside or as alternatives to arthroplasty. The new system features a redesigned screw platform and streamlined instrumentation aimed at improving surgical efficiency and allowing for more personalized patient care in the treatment of distal radius fractures and other wrist injuries.
• In July 2024, Skeletal Dynamics received FDA 510(k) clearance for its Total Wrist Arthroplasty System, a new implant designed for the replacement of painful wrist joints due to conditions such as rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis. The system features a modular design with radial, carpal, and polyethylene lunate components intended to restore joint function while preserving bone stock. This regulatory milestone allowed the company to commercially market the device in the United States, offering surgeons a new motion-preserving option for patients requiring total wrist reconstruction.
• In January 2024, Enovis Corporation completed the acquisition of LimaCorporate S.p.A., a global orthopedic implant manufacturer, in a transaction valued at approximately €800 million. This strategic expansion enhanced Enovis’s position in the global orthopedic reconstruction business, specifically strengthening its portfolio in the extremities market which encompasses hand and wrist solutions. The addition of LimaCorporate provided Enovis with complementary surgical technologies, including 3D-printed Trabecular Titanium implants and a comprehensive revision offering, thereby broadening the company's capabilities to address complex reconstructive needs in the upper extremity sector.
• In January 2024, Extremity Medical entered into a strategic relationship with Henry Schein, Inc. to expand the distribution of its innovative orthopedic extremity implant systems. This collaboration was designed to broaden the market reach of Extremity Medical’s portfolio, including the KinematX Total Wrist Arthroplasty System, which is engineered to mimic the natural range of motion of the human wrist. The partnership aimed to leverage Henry Schein’s extensive global distribution network to increase surgeon access to advanced solutions for treating challenging hand and wrist conditions, such as severe arthritis.

Key Market Players

• Small Bone Innovations Inc
• Zimmer Biomet Holdings Inc
• Integra LifeSciences Corp
• Johnson & Johnson Services, Inc.
• Acumed Inc
• Medartis AG
• Stryker Corporation
• DJO Global Inc
• Anika Therapeutics Inc
• Skeletal Dynamics LLC

By Technology	By End-User	By Region
Total Wrist Replacement (TWR) Total Wrist Fusion (TWF)	Hospitals & Clinics Ambulatory care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Total Wrist Replacement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Total Wrist Replacement Market, By Technology:

• Total Wrist Replacement (TWR)
• Total Wrist Fusion (TWF)

• Total Wrist Replacement Market, By End-User:

• Hospitals & Clinics
• Ambulatory care Centers
• Others

• Total Wrist Replacement Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE